Recon: Thermo Fisher to buy CorEvitas for $913M; Moderna inks deal to make mRNA vaccines in China
ReconJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesDiagnostics/IVDsEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy